Ainos Inc AIMD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/26/24 EDT
1.04UNCH (UNCH)
Volume
4,123
52 week range
0.79 - 6.10
Loading...
  • Open1.04
  • Day High1.05
  • Day Low1.03
  • Prev Close1.04
  • 52 Week High6.10
  • 52 Week High Date07/14/23
  • 52 Week Low0.79
  • 52 Week Low Date02/26/24

Key Stats

  • Market Cap6.192M
  • Shares Out5.95M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.47
  • YTD % Change-49.26

KEY STATS

  • Open1.04
  • Day High1.05
  • Day Low1.03
  • Prev Close1.04
  • 52 Week High6.10
  • 52 Week High Date07/14/23
  • 52 Week Low0.79
  • 52 Week Low Date02/26/24
  • Market Cap6.192M
  • Shares Out5.95M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.47
  • YTD % Change-49.26

RATIOS/PROFITABILITY

  • EPS (TTM)-3.34
  • P/E (TTM)-0.31
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-8.335M
  • ROE (TTM)-46.62%
  • Revenue (TTM)122,110.002
  • Gross Margin (TTM)-207.80%
  • Net Margin (TTM)-11,277.18%
  • Debt To Equity (MRQ)24.39%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ainos Inc

 

Content From Our Affiliates

Profile

MORE
Ainos, Inc. is a diversified healthcare company, which is focused on the development of point-of-care testing (POCT), low-dose VELDONA interferon therapeutics and synthetic Ribonucleic Acid (RNA)-driven preventative medicine. The Company's products include VELDONA clinical-stage human therapeutics, VELDONA Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform. VELDONA Pet is formulated to address a variety of health...
Chun-Hsien Tsai
Chairman of the Board, President, Chief Executive Officer
Hsin-Liang Lee
Chief Financial Officer
Lawrence Lin
Executive Vice President - Operations
Address
8880 Rio San Diego Drive, Ste. 800
San Diego, CA
92108
United States

Top Peers

SYMBOLLASTCHG%CHG
SINT
SINTX Technologies Inc
0.0404+0.0038+10.3825%
NXGL
Nexgel Inc
2.21-0.08-3.28%
BMRA
Biomerica Inc
0.6652-0.0101-1.4991%
LUCD
Lucid Diagnostics Inc
0.6831+0.013+1.94%
NBY
NovaBay Pharmaceuticals Inc
0.0788+0.0018+2.3377%